Global Myocardial Fibrosis Market Size By Product Type (Small Molecule Therapeutic Modality, Protein Therapeutic Modality), By Application (Hospital, Clinics), By Geographic Scope And Forecast

Report ID: 263549|No. of Pages: 202

product image

Global Myocardial Fibrosis Market Size By Product Type (Small Molecule Therapeutic Modality, Protein Therapeutic Modality), By Application (Hospital, Clinics), By Geographic Scope And Forecast

Report ID: 263549|Published Date: Mar 2024|No. of Pages: 202|Base Year for Estimate: 2022|Format:   Report available in PDF formatReport available in Excel Format

Myocardial Fibrosis Market Size And Forecast

Myocardial Fibrosis Market size was valued at USD 765.4 Million in 2022 and is projected to reach USD 1.6 Billion by 2030, growing at a CAGR of 6.1% from 2023 to 2030.

The Global Myocardial Fibrosis Market has grown rapidly due to the increasing incidence of cardiac fibrosis, growing consumer awareness regarding the disease, rising demand for Myocardial Fibrosis treatment, technological advancement as well as the rise in healthcare spending by the governments. These factors will drive the market growth significantly. The Global Myocardial Fibrosis Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

>>> Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=263549

Myocardial Fibrosis Market Size And Forecast

Global Myocardial Fibrosis Market Definition

Myocardial fibrosis, also known as cardiac fibrosis, is a condition characterized by the degeneration of the heart’s muscle cells known as myocytes. It is part of a group of diseases known as fibrosis, which is defined by the solidification or scarring of tissue. Myocardial fibrosis affects not only the heart but also other organs like the lungs and liver. Myocardial fibrosis is also defined as a thickening of the heart valves caused by an abnormal proliferation of cardiac fibroblasts.

Chest pain, some abdominal swelling, nausea, and fatigue are the common symptoms. Myocardial fibrosis, also known as myocardial calcification, is generated by the repeated aggravation of myocardial ischemia and hypoxia caused by moderate to severe coronary atherosclerotic stenosis, finally leading to heart failure with IHD or chronic ischemic heart disease.

>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=263549

Global Myocardial Fibrosis Market Overview

The market overview section of this report mainly consists of the basic dynamics of the market which include drivers, restraints, opportunities, and challenges faced by the industry. The Global Myocardial Fibrosis Market report provides an outlook on the development of the market in terms of revenue throughout the prognosis period. The Global Myocardial Fibrosis Market is expected to experience remarkable growth in the upcoming years owing to the factors increasing incidence of cardiac fibrosis, growing consumer awareness regarding the disease, rising demand for Myocardial Fibrosis treatment, technological advancement as well as the rise in healthcare spending by the governments. These factors will drive the market growth significantly.

Additionally, consumption in major emerging markets is driving the global demand for Myocardial Fibrosis treatment options. A large number of companies are working on the Myocardial Fibrosis pipeline as more growth opportunities emerge in the medium to long-term future. Companies that adapt quickly to change and move their products to advanced stages will emerge as top performers. However, challenges with completing clinical trials on time and insufficient financial support are preventing some Myocardial Fibrosis pipeline companies from progressing their products into Phase 3 or Phase 4 which are expected to be major factors limiting market growth over the forecast period.

Global Myocardial Fibrosis Market: Segmentation Analysis

The Global Myocardial Fibrosis Market is segmented on the basis of Product Type, Application, And Geography.

Myocardial Fibrosis Market Segmentation Analysis

Myocardial Fibrosis Market, By Product Type

  • Small Molecule Therapeutic Modality
  • Protein Therapeutic Modality
  • Peptide Therapeutic Modality
  • Endoglin Antibody Therapeutic Modality
  • Stem Cell Therapeutic Modality
  • RNA Therapeutic Modality
  • Others

Based on Product Type, The market is segmented into Small Molecule Therapeutic Modality, Protein Therapeutic Modality, Peptide Therapeutic Modality, Endoglin Antibody Therapeutic Modality, Stem Cell Therapeutic Modality, RNA Therapeutic Modality, and Others. The Small Molecule Therapeutic Modality segment accounts for the highest revenue share of the Global Myocardial Fibrosis Market in 2020 and is expected to dominate the market over the forecast period owing to they are the most commonly investigated molecules for the treatment of myocardial fibrosis.

Myocardial Fibrosis Market, By Application

  • Hospital
  • Clinics
  • Research Laboratories

Based on Application, The market is segmented into Hospital, Clinics, and Research Laboratories. The Hospital segment is expected to hold the largest revenue share of the Global Myocardial Fibrosis Market during the forecast period owing to the increasing number of patients suffering from myocardial fibrosis, and rising consumer awareness about the disease. Additionally, the availability of various diagnostics and treatment facilities, higher purchasing power, and the presence of highly skilled healthcare professionals are driving the growth of the Global Myocardial Fibrosis Market in the hospital segment.

Myocardial Fibrosis Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

On the basis of Regional Analysis, The Global Myocardial Fibrosis Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Among the regional markets, North America accounts for the largest revenue share in Global Myocardial Fibrosis Market in 2020 and is expected to retain its dominance throughout the forecast period. The revenue growth in the North American market is mainly attributed to the increased investment in R&D activities for the development of technologically advanced treatment procedures for myocardial fibrosis.

Additionally, the increasing geriatric population, rising incidence and prevalence of myocardial fibrosis, rising healthcare sectors, presence of skilled healthcare professionals, and wide availability of technologically advanced treatment procedures are the major factors that boost the market growth across the region.

Key Players

The “Global Myocardial Fibrosis Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Merck, Evotec AG, Miragen Therapeutics, Tracon Pharmaceuticals, Daewoong Pharmaceutical, Galectin Therapeutics, GTx, Invivosciences, Lead Discovery Center, MandalMed.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

Myocardial Fibrosis Market Key Developments And Mergers

  • In April 2020, Merck known as MSD outside the United States and Canada, announced the launch of ONTRUZANT (trastuzumab-dttb), a biosimilar to the reference biologic medicine Herceptin, in the United States. ONTRUZANT is available in single-dose vials of 150 mg and multiple-dose vials of 420 mg.
  • In November 2015, miRagen Therapeutics, Inc., a biopharmaceutical company developing novel microRNA-based therapeutics, announced the start of a Phase 1 clinical trial for anti-fibrosis product candidate MRG-201, a synthetic microRNA mimic (promiR) to microRNA-29b. The Phase 1 clinical trial is being conducted in healthy volunteers and may be expanded to include patients with cutaneous scleroderma.
  • In September 2015, Evotec AG entered into a four-year research collaboration agreement with Pfizer Inc. in the field of tissue fibrosis.

Report Scope

Report AttributesDetails
Study Period

2019-2030

Base Year

2022

Forecast Period

2023-2030

Historical Period

2019-2021

Unit

Value (USD Billion)

Key Companies Profiled

Merck, Evotec AG, Miragen Therapeutics, Tracon Pharmaceuticals, Daewoong Pharmaceutical, Galectin Therapeutics, GTx, Invivosciences.

Segments Covered
  • By Product Type
  • By Application
  • By Geography
Customization scope

Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope

Top Trending Reports

Global GDPR Services Market Size And Forecast

Global Selective Laser Sintering Equipment Market Size And Forecast

Research Methodology of Verified Market Research:

Research Methodology of VMR

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.

Frequently Asked Questions

Myocardial Fibrosis Market was valued at USD 765.4 Million in 2022 and is projected to reach USD 1.6 Billion by 2030, growing at a CAGR of 6.1% from 2023 to 2030.

The Global Myocardial Fibrosis Market has grown rapidly due to the increasing incidence of cardiac fibrosis, growing consumer awareness regarding the disease, technological advancement as well as the rise in healthcare spending by the governments.

The major players are Merck, Evotec AG, Miragen Therapeutics, Tracon Pharmaceuticals, Daewoong Pharmaceutical, Galectin Therapeutics, GTx, Invivosciences.

The Global Myocardial Fibrosis Market is segmented on the basis of Product Type, Application, And Geography.

The sample report for the Myocardial Fibrosis Market can be obtained on demand from the website. Also, 24*7 chat support & direct call services are provided to procure the sample report.
1 INTRODUCTION OF GLOBAL MYOCARDIAL FIBROSIS MARKET 1.1 Overview of the Market 1.2 Scope of Report 1.3 Assumptions 2 EXECUTIVE SUMMARY 3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH 3.1 Data Mining 3.2 Validation 3.3 Primary Interviews 3.4 List of Data Sources 4 GLOBAL MYOCARDIAL FIBROSIS MARKET OUTLOOK 4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis 5 GLOBAL MYOCARDIAL FIBROSIS MARKET, BY PRODUCT TYPE 5.1 Overview 5.2 Small Molecule Therapeutic Modality 5.3 Protein Therapeutic Modality 5.4 Peptide Therapeutic Modality 5.5 Endoglin Antibody Therapeutic Modality 5.6 Stem Cell Therapeutic Modality 5.7 RNA Therapeutic Modality 5.8 Others 6 GLOBAL MYOCARDIAL FIBROSIS MARKET, BY APPLICATION 6.1 Overview 6.2 Hospital 6.3 Clinics 6.4 Research Laboratories 7 GLOBAL MYOCARDIAL FIBROSIS MARKET, BY GEOGRAPHY 7.1 Overview 7.2 North America 7.2.1 U.S. 7.2.2 Canada 7.2.3 Mexico 7.3 Europe 7.3.1 Germany 7.3.2 U.K. 7.3.3 France 7.3.4 Rest of Europe 7.4 Asia Pacific 7.4.1 China 7.4.2 Japan 7.4.3 India 7.4.4 Rest of Asia Pacific 7.5 Rest of the World 7.5.1 Latin America 7.5.2 Middle East and Africa 8 GLOBAL MYOCARDIAL FIBROSIS MARKET COMPETITIVE LANDSCAPE 8.1 Overview 8.2 Company Market Ranking 8.3 Key Development Strategies 9 COMPANY PROFILES 9.1 Merck 9.1.1 Overview 9.1.2 Financial Performance 9.1.3 Product Outlook 9.1.4 Key Developments 9.2 Evotec AG 9.2.1 Overview 9.2.2 Financial Performance 9.2.3 Product Outlook 9.2.4 Key Developments 9.3 Miragen Therapeutics 9.3.1 Overview 9.3.2 Financial Performance 9.3.3 Product Outlook 9.3.4 Key Developments 9.4 Tracon Pharmaceuticals 9.4.1 Overview 9.4.2 Financial Performance 9.4.3 Product Outlook 9.4.4 Key Developments 9.5 Daewoong Pharmaceutical 9.5.1 Overview 9.5.2 Financial Performance 9.5.3 Product Outlook 9.5.4 Key Developments 9.6 Galectin Therapeutics 9.6.1 Overview 9.6.2 Financial Performance 9.6.3 Product Outlook 9.6.4 Key Developments 9.7 GTx 9.7.1 Overview 9.7.2 Financial Performance 9.7.3 Product Outlook 9.7.4 Key Developments 9.8 Invivosciences 9.8.1 Overview 9.8.2 Financial Performance 9.8.3 Product Outlook 9.8.4 Key Developments 9.9 Lead Discovery Center 9.9.1 Overview 9.9.2 Financial Performance 9.9.3 Product Outlook 9.9.4 Key Developments 9.10 MandalMed 9.10.1 Overview 9.10.2 Financial Performance 9.10.3 Product Outlook 9.10.4 Key Developments 10 KEY DEVELOPMENTS 10.1 Product Launches/Developments 10.2 Mergers and Acquisitions 10.3 Business Expansions 10.4 Partnerships and Collaborations 11 Appendix 11.1 Related Research

Report Research Methodology

Research methodology

Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.

This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.

We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:

Exploratory data mining

Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.

All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.

expert data mining

For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.

Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.

Data Collection Matrix

PerspectivePrimary ResearchSecondary Research
Supplier side
  • Fabricators
  • Technology purveyors and wholesalers
  • Competitor company’s business reports and newsletters
  • Government publications and websites
  • Independent investigations
  • Economic and demographic specifics
Demand side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customer

Econometrics and data visualization model

data visualiztion model

Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.

All the research models are customized to the prerequisites shared by the global clients.

The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.

Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.

Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.

Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:

  • Market drivers and restraints, along with their current and expected impact
  • Raw material scenario and supply v/s price trends
  • Regulatory scenario and expected developments
  • Current capacity and expected capacity additions up to 2027

We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.

Primary validation

The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.

The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.

primary validation

Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:

  • Established market players
  • Raw data suppliers
  • Network participants such as distributors
  • End consumers

The aims of doing primary research are:

  • Verifying the collected data in terms of accuracy and reliability.
  • To understand the ongoing market trends and to foresee the future market growth patterns.

Industry Analysis Matrix

Qualitative analysisQuantitative analysis
  • Global industry landscape and trends
  • Market momentum and key issues
  • Technology landscape
  • Market’s emerging opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2027
  • Market revenue estimates and forecasts up to 2027, by technology
  • Market revenue estimates and forecasts up to 2027, by application
  • Market revenue estimates and forecasts up to 2027, by type
  • Market revenue estimates and forecasts up to 2027, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Myocardial Fibrosis Market

report-detail

Download Sample Report

View More Reports